Medicinal Chemistry Research

, Volume 28, Issue 8, pp 1099–1131 | Cite as

Sulfa drug analogs: new classes of N-sulfonyl aminated azines and their biological and preclinical importance in medicinal chemistry (2000–2018)

  • Galal H. ElgemeieEmail author
  • Rasha A. Azzam
  • Rasha E. Elsayed
Review Article


N-sulfonylamino azinones has attracted the interest of numerous researchers and extensive investigations on their biological activities have been done. The present review provides an overview of the patents and reports filed during the last few years pertaining to the synthesis N-sulfonyl azinones as well as their biological and preclinical studies. A brief discussion on the significant biological findings is also provided. It has been established that N-sulfonylamino azinones is privileged heterocycles possessing diuretic, antihypertensive, anti-inflammatory, and anticancer and other biological activities. In particular, a new generation of competitive AMPA receptor antagonist based on N-sulfonylamino 1H-quinazoline-2,4-diones is promising useful in the treatment neurological disorders such as epilepsy and schizophrenia. The scope of these new advances has been also highlighted in this review.


Sulfa drug analogs N-sulfonyl aminated azines Medicinal chemistry N-sulfonyl aminated pyridines N-sulfonyl aminated pyrimidines 



  1. Abdel-Rahman TM (2006) Reactivity of 3-amino-3H-quinazolin-4-one derivatives towards some electrophilic and nucleophilic reagents and using of the products in the building of some interesting heterocycles as anticancer agent. J Heterocycl Chem 43:527–534CrossRefGoogle Scholar
  2. Allgeier H, Auberson Y, Blaettler T, Carcache D, Floersheim P, Froestl W, Guibourdenche C, Kalkman HO, Kallen J, Koller M (2011) Use of 1H-quinazoline-2, 4-diones. (Novartis AG), Int. PCT Pub. No. WO2011161249A1Google Scholar
  3. Allgeier H, Auberson Y, Blaettler T, Carcache D, Floersheim P, Froestl W, Guibourdenche C, Kalkman HO, Kallen J, Koller M (2014) Use of 1H-quinazoline-2, 4-diones. (Novartis AG), Int. PCT Pub. No. US20140018376A1Google Scholar
  4. Allgeier H, Auberson Y, Carcache D, Floersheim P, Guibourdenche C, Froestl W, Kallen J, Koller M, Mattes H, Nozulak J, Orain D, Renaud J (2006a) Preparation of 1H-quinazoline-2, 4-diones as AMPA-receptor ligands. (Novartis AG), Int. PCT Pub. No. WO 2006108591 A1 20061019Google Scholar
  5. Allgeier H, Froestl W, Koller M, Mattes H, Nozulak J, Ofner S, Orain D, Rasetti V, Renaud J, Soldermann N, Floersheim P (2006b) Quinazoline derivatives. (Novartis AG), Int. PCT Pub. No. WO2006010591A2Google Scholar
  6. Al-Rashida M, Hussain S, Hamayoun M, Altaf A, Iqbal J (2014) Sulfa drugs as inhibitors of carbonic anhydrase: new targets for the old drugs. BioMed Res Int 2014:1–10CrossRefGoogle Scholar
  7. Auberson Y, Carcache D, Lerchner A, Nozulak J (2011) 2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl-sulfonamide derivatives. (Novartis AG), Int. PCT Pub. No. WO2011144666A1Google Scholar
  8. Azzam RA, Elgemeie GH (2019) Synthesis and antimicrobial evaluation of novel N-substituted 4-ethylsulfanyl-2-pyridones and triazolopyridines. Med Chem Res 28:62–70CrossRefGoogle Scholar
  9. Azzam RA, Elgemeie GH, Elsayed RE, Jones PG (2017) Crystal structure of N-[6-amino-5-(benzo[d]thiazol-2-yl)-3-cyano-4-methylsulfanyl-2-oxo-1,2-dihydropyridin-1-yl]-4-methylbenzenesulfonamide dimethylformamide monosolvate. Acta Cryst E73:1820–1822Google Scholar
  10. Azzam RA, Elgemeie GH, Osman RR, Jones PG (2019) Crystal structure of potassium [4-amino-5-(benzo[d]thiazol-2-yl)-6-(methylsulfanyl)pyrimidin-2-yl](phenylsulfonyl)azanide dimethylformamide monosolvate hemihydrate. Acta Cryst E75:367–371Google Scholar
  11. Barone M, Catalfo A (2014) Synthesis and structure elucidation of new 3,5-dihydro-4H-pyrimido[5,4-b]indol-4-one derivatives. Arab J Chem 10:S3444–S3450CrossRefGoogle Scholar
  12. Barone M, Graziano ACE, Marrazzo A, Gemmellaro P, Santagati A, Cardile V (2013) Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors. Mol Divers 17:445–458CrossRefGoogle Scholar
  13. Barone M, Pistarà V, Frasca G, Noto C, Scribano M, Catalfo A, Santagati A (2014) Synthesis, structure–activity relationships, and bioactivity evaluation of 6-bromo-quinazolinone derivatives. Med Chem Res 24:2461–2475CrossRefGoogle Scholar
  14. Bayrakdarian M, Berggren K, Davidsson O, Fjellstroem O, Gustafsson D, Hanessian S, Inghardt T, Nilsson I, Nagard M, Simard D, therrien E (2005) New pyridin-2-one compounds useful as inhibitors of thrombin. (Astrazeneca Ab), Int. PCT Pub. No. WO 2005075424 A1 20050818Google Scholar
  15. Bouissane L, El Kazzouli S, Léonce S, Pfeiffer B, Rakib EM, Khouili M, Guillaumet G (2006) Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors. Bioorg Med Chem 14:1078–1088CrossRefGoogle Scholar
  16. Camoutsis C, Geronikaki A, Ciric A, Soković M, Zoumpoulakis P, Zervou M (2010) Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Chem Pharm Bull 58:160–167CrossRefGoogle Scholar
  17. Cherif O, Masmoudi F, Allouche F, Chabchoub F, Trigui M (2015) Synthesis, antibacterial, and antifungal activities of new pyrimidinone derivatives. Heterocycl Commun 21:100–110CrossRefGoogle Scholar
  18. Collins I, Moyes C, Davey WB, Rowley M, Bromidge FA, Quirk K, Atack RJ, McKernan R, Thompson S, Wafford K, Dawson GR, Pike A (2002) 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional selectivity for α2/α3-subtypes of human GABAAreceptor-ion channels. J Med Chem 45:1887–1900CrossRefGoogle Scholar
  19. Elgemeie GH, Ali HA (2003) Reaction of oxime derivatives of β-diketones and β-ketoesters with substituted hydrazides: novel synthesis of nitroso-N-sulfonyl- and nitroso-N-substituted amino pyridines. Synth Commun 33:2087–2094CrossRefGoogle Scholar
  20. Elgemeie GH, Ali HA, Elghandour AH, Abdel-aziz HM (2001) A new general method for substituted 4-alkylthio-N-arylsulfonyl-amino-2-pyridones: reaction of ketene-S,S-acetals with arylsulphonylhydrazides. Phosphorus Sulfur Silicon Relat Elem 170:171–179CrossRefGoogle Scholar
  21. Elgemeie GH, Altalbawy F, Alfaidi M, Azab R, Hassan A (2017a) Synthesis, characterization, and antimicrobial evaluation of novel 5-benzoyl-N-substituted amino- and 5-benzoyl-N-sulfonylamino-4-alkylsulfanyl-2-pyridones. Drug Des Dev Ther 11:3389–3399CrossRefGoogle Scholar
  22. Elgemeie GH, Elghandour AH, Elzanate AM, Masoud WA (2000) Design and synthesis of a new class of N-arylsulfonylaminated pyridines. Phosphorus Sulfur Silicon Relat Elem 163:91–97CrossRefGoogle Scholar
  23. Elgemeie GH, Elghandour AHH, Ali HA, Abdel-Azzez HM (1999) A novel and efficient method for the synthesis of N-arylsulfonylamino-2-pyridones. J Chem Res 0:6–7CrossRefGoogle Scholar
  24. Elgemeie GH, Jones PG (2002) N-[3-Cyano-2-oxo-5,6,7,8-tetrahydroquinoline-1(2H)-yl]-4-methylbenzenesulfonamide. Acta Cryst E58:o1250–o1252Google Scholar
  25. Elgemeie GH, Mahmoud MA, Jones PG (2002) N-(3-Cyano-2-oxo-2,5,6,7,8,9-hexahydro-1H-cyclohepta[b]pyridin-1-yl)-4-methylbenzenesulfonamide. Acta Cryst E58:o1293–o1295Google Scholar
  26. Elgemeie GH, Salah AM, Abbas NS, Hussein HA, Mohamed RA (2017b) Pyrimidine non-nucleoside analogs: a direct synthesis of a novel class of N-substituted amino and N-sulfonamide derivatives of pyrimidines. Nucleosides Nucleotides Nucleic Acids 36:213–223CrossRefGoogle Scholar
  27. Elgemeie GH, Sayed SH (2003) Regioselective synthesis of a new class of N-arylaminated biheterocycles. Phosphorus Sulfur Silicon Relat Elem 178:465–473CrossRefGoogle Scholar
  28. Elgemeie GH, Sood SA (2006) First synthesis of N‐substituted amino and N‐sulfonylaminated methylthiopyrimidines: reaction of dimethyl N-cyanodithioiminocarbonate with substituted hydrazides. Synth Commun 36:743–753CrossRefGoogle Scholar
  29. El-Hashash MA, Darwish KM, Rizk SA, El-Bassiouny FA (2011) The uses of 2-ethoxy-(4H)-3,1-benzoxazin-4-one in the synthesis of some quinazolinone derivatives of antimicrobial activity. Pharmaceuticals 4:1032–1051CrossRefGoogle Scholar
  30. El-Moghazy SM, Abdel-Gawad NM, Eissa AAM, Youssef RM (2012) Design and synthesis of some quinazoline derivatives of anticipated antimicrobial activity. J Pharm Pharm Sci 4:540–553Google Scholar
  31. Faidallah HM, Khan KA, Asiri AM (2011) Synthesis and characterization of a novel series of benzenesulfonylurea and thiourea derivatives of 2H-pyran and 2H-pyridine-2-ones as antibacterial, antimycobacterial and antifungal agents. Eur J Chem 2:243–250CrossRefGoogle Scholar
  32. Faidallah HM, Rostom SAF, Khan KA, Basaif SA (2013) Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents. J Enzyme Inhib Med Chem 28:926–935CrossRefGoogle Scholar
  33. Farag DB, Farag NA, Esmat A, Abuelezz SA, Abdel-Salam Ibrahim E, Abou El Ella DA (2015) Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors. Med Chem Commun 6:283–299CrossRefGoogle Scholar
  34. Faught E (2014) BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy. Exp Opin Investig Drug 23:107–113CrossRefGoogle Scholar
  35. Fossa P, Menozzi G, Dorigo P, Floreani M, Mosti L (2003) Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone. Bioorg Med Chem 11:4749–4759CrossRefGoogle Scholar
  36. Gadad A (2000) Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives. Eur J Med Chem 35:853–857CrossRefGoogle Scholar
  37. Gezegen H, Ceylan M, Karaman İ, Şahin E (2014) Synthesis, characterization, and antibacterial activity of novel pyridones. Synth Commun 44:1084–1093CrossRefGoogle Scholar
  38. Ghorab M, Ragab F, Heiba HI, Bayomi A (2014) Novel quinazoline derivatives bearing a sulfapyridine moiety as anticancer and radiosensitizing agents. J Heterocyclic Chem 51:E255–E262CrossRefGoogle Scholar
  39. Gomez-Mancilla B, Brand R, Jürgens TP, Göbel H, Sommer C, Straube A, Evers S, Sommer M, Campos V, Kalkman HO, Hariry S, Pezous N, Johns D, Diener H-C (2014) Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia 34:103–113CrossRefGoogle Scholar
  40. Hameed A, Al-Rashida M, Uroos M, Ali SA, Arshia IM, Khan KM (2018) Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016). Expert Opin Ther Pat 28:281–297CrossRefGoogle Scholar
  41. Hanada T (2014) The AMPA receptor as a therapeutic target in epilepsy: preclinical and clinical evidence. J Rec Ligand Chan Res 7:39–50Google Scholar
  42. Hassan MA, Younes AMM, Taha MM, Abdel-Monsef A-BH (2011) Synthesis and reactions of 3-aminotetrachloroquinazolin-2,4-dione. Eur J Chem 2:514–518CrossRefGoogle Scholar
  43. Hekal MH, Abu El-Azm FSM (2018) New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: synthesis and cytotoxic evaluation. Synth Commun 48:2391–2402CrossRefGoogle Scholar
  44. Hossan A, Abu-Melha H, Al-Omar M, Amr A (2012) Synthesis and antimicrobial activity of some new pyrimidinone and oxazinone derivatives fused with thiophene rings using 2-Chloro-6-ethoxy-4-acetylpyridine as starting material. Molecules 17:13642–13655CrossRefGoogle Scholar
  45. Isik S, Kockar F, Aydin M, Arslan O, Guler OO, Innocenti A, Scozzafava A, Supuran CT (2009) Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. Bioorg Med Chem 17:1158–1163CrossRefGoogle Scholar
  46. Jagani CL, Sojitra NA, Vanparia SF, Patel TS, Dixit RB, Dixit BC (2011) A convergent microwave assisted synthesis of 4-amino-N-(4-oxo-2-substituted-4H-quinazolin-3-yl)benzenesulfonamide derivatives. Arkivoc 2011:221–237Google Scholar
  47. Kalkman HO, Mattes H (2012). 1H-quinazoline-2,4-diones for use in the treatment of neuronal ceroid lipofuscinosis. (Novartis AG), Int. PCT Pub. No. US2012/0122903A1, No. WO 2011/009951 A1Google Scholar
  48. Kamel M, Ali H, Anwar M, Mohamed N, Soliman AM (2010) Synthesis, antitumor activity and molecular docking study of novel Sulfonamide-Schiff’s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. Eur J Med Chem 45:572–580CrossRefGoogle Scholar
  49. Kasteleijn-Nolst Trenité D, Brandt C, Mayer T, Rosenow F, Schmidt B, Steinhoff BJ, Gardin A, Imbert G, Johns D, Sagkriotis A, Kucher K (2015) Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: clear PK/PD relationship. Epilepsia 56:924–932CrossRefGoogle Scholar
  50. Koller M, ingenhoehl K, Schmutz M, Vranesic I-T, Kallen J, Auberson YP, Carcache DA, Mattes H, Ofner S, Orain D, Urwyler S (2011) Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity. Bioorg Med Chem Lett 21:3358–3361CrossRefGoogle Scholar
  51. Kumar A, Kumar N, Roy P, Sondhi SM, Sharma A (2015) Microwave-assisted synthesis of benzenesulfonohydrazide and benzenesulfonamide cyclic imide hybrid molecules and their evaluation for anticancer activity. Med Chem Res 24:3760–3771CrossRefGoogle Scholar
  52. Li A, Ouyang Y, Wang Z, Cao Y, Liu X, Ran L, Li C, Li L, Zhang L, Qiao K, Xu W, Huang Y, Zhang Z, Tian C, Liu Z, Jiang S, Shao Y, Du Y, Ma L, Wang X, Liu J (2013) Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains. J Med Chem 56:3593–3608CrossRefGoogle Scholar
  53. Medina-Franco JL, Martínez-Mayorga K, JuárezGordiano C, Castillo R (2007) Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors. Chem Med Chem 2:1141–1147CrossRefGoogle Scholar
  54. Mironov AF, Grin MA, Nochovny SA, Toukach PV (2003a) Novel cycloimides in the chlorophyll a series. Mendeleev Commun 13:156–157CrossRefGoogle Scholar
  55. Mironov AF, Grin MA, Tsiprovskiy AG, Kachala VV, Karmakova TA, Plyutinskaya AD, Yakubovskaya RI (2003b) New bacteriochlorin derivatives with a fused N-aminoimide ring. J Porphyr. J Porphyr Phthalocyanines 7:725–730CrossRefGoogle Scholar
  56. Mohamed MA (2010) Synthesis of some new pyridones, fused pyrimidines, and fused 1,2,4-triazines. J Heterocycl Chem 47:517–523Google Scholar
  57. Nasr T, Bondock S, Eid S (2014) Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety. Eur J Med Chem 84:491–504CrossRefGoogle Scholar
  58. Orain D, Ofner S, Koller M, Carcache DA, Froestl W, Allgeier H, Rasetti V, Nozulak J, Mattes H, Soldermann N, Floersheim P, Desrayaud S, Kallen J, Lingenhoehl K, Urwyler S (2012) 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorg Med Chem Lett 22:996–999CrossRefGoogle Scholar
  59. Orain D, Tasdelen E, Haessig S, Koller M, Picard A, Dubois C, Mattes H (2016) Design and synthesis of selurampanel, a novel orally active and competitive AMPA receptor antagonist. ChemMedChem 12:197–201CrossRefGoogle Scholar
  60. Padithem M, Annapurnapadmavathi D, Prasunamba PL, Saraladevi C (2013) Synthesis, characterization and microbial activity of some 2-substituted-3-benzene sulfonamido-4(3H)-qunazolinones; an experimental and theoretical approach. J Pharm Pharm Sci 5:179–182Google Scholar
  61. Patel NB, Patel JC, Patel VN (2010a) Synthesis and antimicrobial activity of quinazolin-4(3H)-ones incorporating sulfonamido-4-thiazolidinone. Chin J Chem 28:1989–1997CrossRefGoogle Scholar
  62. Patel NB, Patel VN, Patel HR, shaikh FM, Patel JC (2010b) Synthesis and microbial studies of (4-oxo-thiazolidinyl)sulfonaimides bearing quninazolin-(3H)ones. Acta Pol Pharm 67:267–275Google Scholar
  63. Patel NB, Shaikh FM, Patel VN, Patel HR, Patel JC (2010c) New thiazolidinyl quinazolinones and their microbial activity studies. Int J Drug Des Discov 1:221–227Google Scholar
  64. Patel NB, Shaikh FM, Patel VN, Patel HR, Shaikh AR, Patel JN (2010d) Synthesis and antimicrobial activity of new disubstituted 4-thiazolidinones of diclofenac analogue. Int J Drug Des Discov 3:921–929Google Scholar
  65. Rahman MU, Rathore A, Siddiqui AA, Parveen G, Yar MS (2014) Synthesis and characterization of quinazoline derivatives: search for hybrid molecule as diuretic and antihypertensive agents. J Enzyme Inhib Med Chem 29:733–743CrossRefGoogle Scholar
  66. Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-ul-Ain SA, Yar M (2015) Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer’s disease: in vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase. Bioorg Chem 63:64–71CrossRefGoogle Scholar
  67. Sojitra NA, Dixit RB, Patel RK, Patel JP, Dixit BC (2016) Classical and microwave assisted synthesis of new 4-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-ylazo)-N-(2-substituted-4-oxo-4H-quinazolin-3-yl)benzenesulfonamide derivatives and their antimicrobial activities. J Saudi Chem Soc 20:S29–S37CrossRefGoogle Scholar
  68. Sojitra NA, Patel TS, Dixit RB, Dixit BC (2013) Synthesis of rhodanine substituted 4(3H)-quinazolinone derivatives and their antimicrobial evaluation. J Chem Acta 2:46–52Google Scholar
  69. Verrier N, Hoarau C, Celanire S, Marsais F (2008) A convenient synthesis of cyclopenta[b]pyridin-2,5-dione as a non- glycosidic cardiotonic agent. Arkivoc 7:92–100Google Scholar
  70. Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47:550–557CrossRefGoogle Scholar
  71. Zhou Y, Murphy DE, Sun Z, Gregor VE (2004) Novel parallel synthesis of N-(4-oxo-2-substituted-4H-quinazolin-3-yl)-substituted sulfonamides. Tetrahedron Lett 45:8049–8051CrossRefGoogle Scholar
  72. Zielinski J, Vrettos J, Ji Q, Patel S (2012) Fomulation comprising 1H-quinazoline-2, 4-dione AMPA receptor antagonists, in the form of immediate release tablets and preparation thereof. (Novartis AG), Int. PCT Pub. No. US 2012/0263791 A1, No. WO 2011/079119 A1Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Galal H. Elgemeie
    • 1
    Email author
  • Rasha A. Azzam
    • 1
  • Rasha E. Elsayed
    • 1
  1. 1.Chemistry Department, Faculty of ScienceHelwan UniversityCairoEgypt

Personalised recommendations